Interpersonal Psychotherapy in Adolescents With Polycystic Ovary Syndrome

University of Colorado, Denver1 site in 1 country30 target enrollmentSeptember 20, 2021

ConditionsInterpersonal Psychotherapy Polycystic Ovary Syndrome

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Interpersonal Psychotherapy
Sponsor: University of Colorado, Denver
Enrollment: 30
Locations: 1
Primary Endpoint: Center for Epidemiologic Studies-Depression Scale
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The main purpose of this study is to find out whether taking part in a group-based interpersonal psychotherapy (IPT) program designed to improve mood and lessen stress in girls with PCOS will improve depression, unhealthy eating behaviors, weight, and insulin resistance.

Registry

clinicaltrials.gov

Start Date

September 20, 2021

End Date

July 14, 2023

Last Updated

2 years ago

Study Type

Interventional

Study Design

Single Group

Sex

Female

Investigators

Sponsor

University of Colorado, Denver

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Diagnosed with PCOS duration \> 3 months
•12-17 years old
•BMI \> 75th percentile
•CESD \> 16

Exclusion Criteria

•Weekly or bi-weekly therapy with licensed behavioral health provider
•Inability to speak, read, or write in English (teen)
•Major medical conditions
•HbA1c \> 7.0%
•Hormonal contraception \< 3 months
•Metformin \< 3 months
•Antidepressants/psychotropic medications \< 4 weeks

Outcomes

Primary Outcomes

Center for Epidemiologic Studies-Depression Scale

Time Frame: 6-Month Follow-Up Assessment

Depression symptoms will be assessed by the Center for Epidemiologic Studies-Depression Scale. Scores range from 1 to 4. The scoring of positive items is reversed. Possible range of scores is zero to 60, with the higher scores indicating the presence of more symptomatology.

Secondary Outcomes

Emotional Eating Scale Adapted for Children(Baseline, 6-Week Follow-Up Assessment, 6-Month Follow-Up Assessment)
BMI(Baseline, 6-Week Follow-Up Assessment, 6-Month Follow-Up Assessment)
Insulin Resistance(Baseline, 6-Week Follow-Up Assessment, 6-Month Follow-Up Assessment)
Loss-of-Control Eating Disorder Questionnaire(Baseline, 6-Week Follow-Up Assessment, 6-Month Follow-Up Assessment)
Dysglycemia(Baseline, 6-Week Follow-Up Assessment, 6-Month Follow-Up Assessment)
Reward Based Eating Drive Scale(Baseline, 6-Week Follow-Up Assessment, 6-Month Follow-Up Assessment)
Dyslipidemia(Baseline, 6-Week Follow-Up Assessment, 6-Month Follow-Up Assessment)